DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.88+0.37 (+3.21%)
Close on Nov 11, 2026Market cap $746.99MP/E –Yield –
DBV Technologies total assets
Total assets on the balance sheet at the end of each period.
DBV Technologies's total assets was $215.40M at Sep 30, 2026. For fiscal 2025 it was $233.70M, up 255.9% from the year before. The highest annual figure on record is $272.25M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $233.70M | +255.9% |
| FY2024 | Dec 31, 2024 | $65.66M | -64.1% |
| FY2023 | Dec 31, 2023 | $182.99M | -25.8% |
| FY2022 | Dec 31, 2022 | $246.52M | +68.0% |
| FY2021 | Dec 31, 2021 | $146.72M | -46.1% |
| FY2020 | Dec 31, 2020 | $272.25M | +0.2% |
| FY2019 | Dec 31, 2019 | $271.73M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $215.40M | +94.9% |
| Q2 FY2026 | Jun 30, 2026 | $223.20M | +55.6% |
| Q1 FY2026 | Mar 31, 2026 | $266.40M | +426.9% |
| Q4 FY2025 | Dec 31, 2025 | $233.70M | +255.9% |
| Q3 FY2025 | Sep 30, 2025 | $110.50M | +18.7% |
| Q2 FY2025 | Jun 30, 2025 | $143.43M | +25.6% |
| Q1 FY2025 | Mar 31, 2025 | $50.56M | -65.3% |
| Q4 FY2024 | Dec 31, 2024 | $65.66M | -64.1% |
| Q3 FY2024 | Sep 30, 2024 | $93.06M | -51.0% |
| Q2 FY2024 | Jun 30, 2024 | $114.19M | -47.5% |
| Q1 FY2024 | Mar 31, 2024 | $145.90M | -37.4% |
| Q4 FY2023 | Dec 31, 2023 | $182.99M | -25.8% |
| Q3 FY2023 | Sep 30, 2023 | $189.78M | -23.5% |
| Q2 FY2023 | Jun 30, 2023 | $217.52M | -23.7% |
| Q1 FY2023 | Mar 31, 2023 | $232.93M | +98.1% |
| Q4 FY2022 | Dec 31, 2022 | $246.52M | +68.0% |
| Q3 FY2022 | Sep 30, 2022 | $248.12M | +45.2% |
| Q2 FY2022 | Jun 30, 2022 | $284.98M | +42.1% |
| Q1 FY2022 | Mar 31, 2022 | $117.58M | -46.9% |
| Q4 FY2021 | Dec 31, 2021 | $146.72M | -46.1% |
| Q3 FY2021 | Sep 30, 2021 | $170.92M | -37.1% |
| Q2 FY2021 | Jun 30, 2021 | $200.58M | – |
| Q1 FY2021 | Mar 31, 2021 | $221.41M | – |
| Q4 FY2020 | Dec 31, 2020 | $272.25M | – |
| Q4 FY2019 | Dec 31, 2019 | $271.73M | – |
See a number that looks wrong?